MANAGING "MANAGED CARE": The Changing Role of The FDA In Light of A Changing Market

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Ragade, Anjani	en_US
dc.date.accessioned	2012-07-06T21:36:08Z
dc.date.issued	1997	en_US
dc.identifier.citation	MANAGING "MANAGED CARE": The Changing Role of The FDA In Light of A Changing Market (1997 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965585
dc.description.abstract	Change creates the necessity for more change. Advances in medical technology, and the incentives of a fee-for-service insurance system, drove up the costs of care. In response, insurers and purchasers of care began to seek ways to control these increases in health care costs. Eventually, "managed care" organizations sprouted which combined both the delivery and financing of care to provide "cost-effective" care. This combination not only changed many doctors' incentives to provide care, but more broadly transformed the overall structure of the American health care market.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	managed care	en
dc.subject	HMO	en
dc.subject	health care reform	en
dc.title	MANAGING "MANAGED CARE": The Changing Role of The FDA In Light of A Changing Market	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-07-06T21:36:08Z